Clinical Trials Browser

Phase 2 × Terminated × dupilumab × Clear all

NCT03736967 2021-11-01

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2 Terminated

206 enrolled 34 charts

Dermatitis, Atopic, Lymphoma, Follicular

NCT03886493 2021-10-15

Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer

Phase 2 Terminated

7 enrolled 7 charts

Prostatic Neoplasms